 |
|
Why Are People Still Dying From Melanoma?
Arch Dermatol. 1999;135:1534-1536.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
DRAMATIC INCREASE IN THE INCIDENCE OF THIN MELANOMA
In 1985, Bernard Ackerman wrote an influential editorial entitled "No One Should Die of Malignant Melanoma."1 Ackerman suggested that more ambitious early detection efforts had the potential to identify melanoma before it had the chance to invade and lead to metastases and death. Since then, efforts to find melanomas at an early stage have been widespread and successful insofar as many studies have shown that a large proportion of melanoma is now discovered at a thinner, potentially curable stage.2-5 However, it is not clear that these efforts to uncover more melanomas at an earlier stage have succeeded in affecting the death rate from melanoma. The article in this month's ARCHIVES by Lipsker et al6 is a conservative analysis of increases in melanoma incidence within categories of Breslow thickness in Bas-Rhin, France. They show that the entire increase in melanoma incidence occurred among lesions that were thin (<1.00 mm), and that . . . [Full Text of this Article]
PLAUSIBLE EXPLANATIONS FOR THE INCREASE IN THE INCIDENCE OF THIN MELANOMA
Increased Diagnosis of a Nonmetastasizing Form of Melanoma
Increased Incidence Among Those of Higher Socioeconomic Status Data Quality Delayed Screening Effect
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Tumor Screening and Biology in Malignant Melanomas
Pozo and Diaz-Cano
Arch Dermatol 2000;136:934-935.
FULL TEXT
|
